Royalties on Sales. In addition to the payments referred to in Section 10.2, UCB shall make the following quarterly royalty payments to Dermira within [*] Business Days after the end of each Calendar Quarter during the Term, and shall provide Dermira with such information as needed for Dermira to meet its audit or financial reporting obligations in a timely manner. The amount of each such payment shall, subject to Section 10.6, be calculated as an amount equal to the applicable percentage of Gross Margin. UCB shall accompany each such payment with a statement setting forth the calculation for such payment, including the amount of Extended Unit Sales, WAC, deductions included in the definition of Net Sales, Royalty Bearing Sales and deductions from Royalty Bearing Sales included in the definition of Gross Margin. The applicable percentage of Gross Margin shall be determined as follows: The portion of Annual Net Sales on or after the Trigger Date of up to US$[*] in a given Calendar Year [*] The portion of Annual Net Sales on or after the Trigger Date in a given Calendar Year over US$[*] and up to US$150,000,000 [*] The portion of Annual Net Sales on or after the Trigger Date in a given Calendar Year of over US$150,000,000 50
Appears in 3 contracts
Sources: Development and Commercialisation Agreement (Dermira, Inc.), Development and Commercialisation Agreement (Dermira, Inc.), Development and Commercialisation Agreement (Dermira, Inc.)